CHINA SHINEWAY PHARMACEUTICAL GROUP LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.45 HKD | +2.38% |
|
-4.64% | +29.99% |
| Sales 2023 | 4.52B 624M 4.89B | Sales 2024 * | 5.24B 724M 5.67B | Capitalization | 6.6B 911M 7.14B |
|---|---|---|---|---|---|
| Net income 2023 | 970M 134M 1.05B | Net income 2024 * | 1.13B 156M 1.22B | EV / Sales 2023 | 1.11 x |
| Net cash position 2023 * | - 0 0 | Net cash position 2024 * | 5.74K 792.15 6.2K | EV / Sales 2024 * | 1.26 x |
| P/E ratio 2023 |
5.16
x | P/E ratio 2024 * |
6.01
x | Employees | 3,533 |
| Yield 2023 * |
5.05% | Yield 2024 * |
6.49% | Free-Float | 33.69% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +2.38% | ||
| 1 week | -4.64% | ||
| Current month | -2.88% | ||
| 1 month | -10.51% | ||
| 3 months | +19.32% | ||
| 6 months | +26.00% | ||
| Current year | +29.99% |
1 week
9.05
9.70
1 month
9.0510.58
Current year
7.2210.72
1 year
6.5510.72
3 years
4.6310.72
5 years
4.6010.72
10 years
4.6018.54
| Managers | Title | Age | Since |
|---|---|---|---|
Zhen Jiang Li
FOU | Founder | 68 | 02-08-13 |
King Kuen Hung
IRC | Investor Relations Contact | 58 | - |
Baochang Liu
SAM | Sales & Marketing | 44 | 19-11-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Zhen Jiang Li
FOU | Founder | 68 | 02-08-13 |
Wencheng Zhou
BRD | Director/Board Member | 48 | 20-09-30 |
Yun Xia Xin
FOU | Founder | 60 | 02-08-13 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 4 M€ | -4.41% | - | |
| 0.00% | 117 M€ | -1.55% | - | |
| 0.00% | 34 M€ | +1.25% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-19 | 9.45 | +2.38% | 541,000 |
| 24-04-18 | 9.23 | -0.75% | 705,000 |
| 24-04-17 | 9.3 | -0.85% | 535,000 |
| 24-04-16 | 9.38 | 0.00% | 351,000 |
| 24-04-15 | 9.38 | -3.60% | 628,000 |
Delayed Quote Hong Kong S.E., April 19, 2024 at 04:08 am EDT
More quotes
China Shineway Pharmaceutical Group Limited is an investment holding company principally engaged in the research and development, manufacture and trading of modern Chinese medicines. Its main products include injections, soft capsules and granules. The Companyâs subsidiaries include Yuan Da International Limited, Hong Zhan International Limited and Shineway Pharmaceutical Sales Company Limited.
Sector
Pharmaceuticals
Calendar
2024-04-28
- Final dividend
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
8.735
CNY
Average target price
13.02
CNY
Spread / Average Target
+49.06%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +29.99% | 890M | |
| +20.91% | 43.54B | |
| +16.96% | 21.74B | |
| +9.05% | 13.53B | |
| +7.98% | 13.02B | |
| +33.80% | 11.28B | |
| -11.05% | 6.99B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +6.64% | 5.09B |
- Stock Market
- Equities
- 2877 Stock
